Author's response Comments on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v (PresVu eye drops) versus placebo ophthalmic solution for the treatment of presbyopia – A multicentric clinical trial
Author's response Comments on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v (PresVu eye drops) versus placebo ophthalmic solution for the treatment of presbyopia – A multicentric clinical trial
Sabyasachi Sengupta, Tejal Garasiya, Vidya Ajila, Parul Singh et al.
Journal
Indian Journal of Ophthalmology
Topics
Ophthalmology and Visual Impairment Studies
article
Author's response Comments on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v (PresVu eye drops) versus placebo ophthalmic solution for the treatment of presbyopia – A multicentric clinical trial
Aravind Eye Hospital (IN), Ganesh Shankar Vidyarthi Memorial Medical College (IN), Department of Pharmaceuticals (IN), Jyotirmay Eye Clinic (IN), Biocon (India) (IN), Directorate of Medicinal and Aromatic Plants Research (IN), Vasan Eye Care Hospital (IN), ICMR-National Institute of Virology (IN)